FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116089003: Cytarabine liposome (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177356019 Cytarabine liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674830015 Cytarabine liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
177356019 Cytarabine liposome en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
177356019 Cytarabine liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
674830015 Cytarabine liposome (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
674830015 Cytarabine liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cytarabine liposome Is a Product containing cytarabine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome Is a Pyrimidine analog (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome Is a Cytarabine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome Is a Liposomal agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome Has disposition Antimetabolite true Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome Is modification of (attribute) Cytarabine (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Cytarabine (liposomal) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposomal 50mg/5mL injection 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine liposome only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1
Cytarabine liposome only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1
Cytarabine liposome and daunorubicin liposome only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Cytarabine liposome Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start